100 related articles for article (PubMed ID: 28106922)
1. Recurrence risk of venous thromboembolism and hormone use in women from England: a cohort study using clinical practice research datalink.
Kiconco S; Abdul Sultan A; Grainge MJ
Br J Haematol; 2017 Apr; 177(1):127-135. PubMed ID: 28106922
[TBL] [Abstract][Full Text] [Related]
2. Hormone therapy and risk of venous thromboembolism among postmenopausal women in Taiwan - a 10-year nationwide population-based study.
Lee CH; Cheng CL; Kao Yang YH; Lin LJ
Circ J; 2015; 79(5):1107-14. PubMed ID: 25753572
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for recurrent venous thromboembolism in young and middle-aged women.
Ljungqvist M; Sonnevi K; Bergendal A; Holmström M; Kieler H; Lärfars G
Thromb Res; 2014 May; 133(5):762-7. PubMed ID: 24613699
[TBL] [Abstract][Full Text] [Related]
4. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
[TBL] [Abstract][Full Text] [Related]
5. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
White RH; Chan WS; Zhou H; Ginsberg JS
Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
[TBL] [Abstract][Full Text] [Related]
6. Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
Blanco-Molina Á; Trujillo-Santos J; Pesavento R; Rosa V; Falgá C; Tolosa C; Mazzolai L; Sampériz Á; Duce R; Monreal M;
Thromb Res; 2017 Mar; 151 Suppl 1():S6-S10. PubMed ID: 28262237
[TBL] [Abstract][Full Text] [Related]
7. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
Le Gal G; Kovacs MJ; Carrier M; Do K; Kahn SR; Wells PS; Anderson DA; Chagnon I; Solymoss S; Crowther M; Righini M; Lacut K; White RH; Vickars L; Rodger M
Thromb Haemost; 2010 Sep; 104(3):498-503. PubMed ID: 20539910
[TBL] [Abstract][Full Text] [Related]
8. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
[TBL] [Abstract][Full Text] [Related]
9. Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism.
Renoux C; Dell'Aniello S; Brenner B; Suissa S
Pharmacoepidemiol Drug Saf; 2017 May; 26(5):554-560. PubMed ID: 28326633
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer.
Martinez C; Cohen AT; Bamber L; Rietbrock S
Thromb Haemost; 2014 Aug; 112(2):255-63. PubMed ID: 24695909
[TBL] [Abstract][Full Text] [Related]
11. Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort study.
Aziz D; Skeith L; Rodger MA; Sabri E; Righini M; Kovacs MJ; Carrier M; Kahn SR; Wells PS; Anderson DR; Chagnon I; Solymoss S; Crowther MA; White RH; Le Gal G
J Thromb Haemost; 2021 Jun; 19(6):1526-1532. PubMed ID: 33724705
[TBL] [Abstract][Full Text] [Related]
12. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
Olié V; Plu-Bureau G; Conard J; Horellou MH; Canonico M; Scarabin PY
Menopause; 2011 May; 18(5):488-93. PubMed ID: 21178641
[TBL] [Abstract][Full Text] [Related]
13. When are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data.
Walker AJ; West J; Card TR; Crooks C; Kirwan CC; Grainge MJ
Blood; 2016 Feb; 127(7):849-57; quiz 953. PubMed ID: 26574606
[TBL] [Abstract][Full Text] [Related]
14. Long-term recurrence risk after a first venous thromboembolism in men and women under 50 years old: A French prospective cohort.
de Moreuil C; Le Mao R; Le Moigne E; Pan-Petesch B; Tromeur C; Hoffmann C; Salaun PY; Nonent M; Danguy des Déserts M; Savary X; Guegan M; Poulhazan E; Leroyer C; Lacut K; Couturaud F
Eur J Intern Med; 2021 Feb; 84():24-31. PubMed ID: 33214024
[TBL] [Abstract][Full Text] [Related]
15. Iron deficiency: a novel risk factor of recurrence in patients after unprovoked venous thromboembolism.
Potaczek DP; Jankowska EA; Wypasek E; Undas A
Pol Arch Med Wewn; 2016; 126(3):159-65. PubMed ID: 26942727
[TBL] [Abstract][Full Text] [Related]
16. Warfarin Discontinuation in Patients With Unprovoked Venous Thromboembolism: A Large US Insurance Database Analysis.
Xie L; Liu X; Phatak H; Mardekian J; Tan W; Baser O; Ramacciotti E
Am J Ther; 2016; 23(6):e1744-e1753. PubMed ID: 26214203
[TBL] [Abstract][Full Text] [Related]
17. Recurrence after stopping anticoagulants in women with combined oral contraceptive-associated venous thromboembolism: A systematic review and meta-analysis.
Abdulrehman J; Elbaz C; Aziz D; Parpia S; Fazelzad R; Eischer L; Rodger MA; Cannegieter SC; Ten Cate-Hoek A; Nagler M; Schulman S; Rezende SM; Olié V; Palareti G; Marcucci M; Douketis J; Poli D; Zabczyk M; de Sousa DA; Miranda B; Cushman M; Tosetto A; Le Gal G; Kearon C; Skeith L
Br J Haematol; 2022 Oct; 199(1):130-142. PubMed ID: 35877546
[TBL] [Abstract][Full Text] [Related]
18. B blood group: A strong risk factor for venous thromboembolism recurrence.
Baudouy D; Moceri P; Chiche O; Bouvier P; Schouver ED; Cerboni P; Gibelin P; Ferrari E
Thromb Res; 2015 Jul; 136(1):107-11. PubMed ID: 25981188
[TBL] [Abstract][Full Text] [Related]
19. Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism.
Klil-Drori AJ; Yin H; Tagalakis V; Aprikian A; Azoulay L
Eur Urol; 2016 Jul; 70(1):56-61. PubMed ID: 26138040
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives.
Vaillant-Roussel H; Ouchchane L; Dauphin C; Philippe P; Ruivard M
Contraception; 2011 Nov; 84(5):e23-30. PubMed ID: 22018134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
